Cargando…

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis

Purpose: To evaluate the efficiency and side effects of stereotactic radiation therapy (SRT) with or without other treatments for brain metastases (BM) from various primary tumors. Methods: This was a retrospective analysis of 161 patients with brain metastases treated with SRT. Clinical data, EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Lei, Qing, Shuiwang, Zhu, Xiaofei, Ju, Xiaoping, Cao, Yangsen, Jia, Zhen, Shen, Yuxin, Cao, Fei, Fang, Fang, Zhang, Huojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914765/ https://www.ncbi.nlm.nih.gov/pubmed/31921625 http://dx.doi.org/10.3389/fonc.2019.01352

Ejemplares similares

Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial
por: Zhu, Xiaofei, et al.
Publicado: (2016)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2018)

Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database
por: Zhu, Xiaofei, et al.
Publicado: (2018)

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer
por: Zhao, Xianzhi, et al.
Publicado: (2018)

Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2018)

Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications
por: Zhu, Xiaofei, et al.
Publicado: (2020)

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study
por: Zhu, Xiaofei, et al.
Publicado: (2020)

Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration
por: Cao, Yangsen, et al.
Publicado: (2023)

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles
por: Zhu, Xiaofei, et al.
Publicado: (2020)

Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial
por: Ye, Yusheng, et al.
Publicado: (2022)

Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells
por: Cao, Yangsen, et al.
Publicado: (2018)

CBCT Verification of SRT for Patients With Brain Metastases
por: Papp, Judit, et al.
Publicado: (2022)

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study
por: Jia, Zhen, et al.
Publicado: (2023)

Correction: Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study
por: Jia, Zhen, et al.
Publicado: (2023)

Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results
por: Qing, Shuiwang, et al.
Publicado: (2021)

Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial
por: Zhu, Xiaofei, et al.
Publicado: (2022)

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
por: Xu, Chenyang, et al.
Publicado: (2022)

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy
por: Zhu, Xiaofei, et al.
Publicado: (2021)

Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China
por: Zhao, Xianzhi, et al.
Publicado: (2020)

Single-fraction SRS and multiple-fraction SRT for brain metastases from colorectal cancer
por: Li, Yong, et al.
Publicado: (2022)

Implementation of superficial radiation therapy (SRT) using SRT‐100 Vision™ for non‐melanoma skin cancer in a Radiation Oncology clinic
por: Lee, Yongsook C., et al.
Publicado: (2023)

Stereotactic body radiation therapy for the treatment of lymph node metastases: a retrospective mono-institutional study in a large cohort of patients
por: Caivano, Donatella, et al.
Publicado: (2023)

A Single-Institution Analysis of 126 Patients Treated with Stereotactic Radiosurgery for Brain Metastases
por: Harris, Kevin B., et al.
Publicado: (2017)

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery
por: Chetvertkov, Mikhail, et al.
Publicado: (2020)

Feasibility and dosimetric evaluation of single- and multi-isocentre stereotactic body radiation therapy for multiple liver metastases
por: Tang, Chunbo, et al.
Publicado: (2023)

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer
por: Xu, Bichun, et al.
Publicado: (2023)

Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients
por: Kuntz, L., et al.
Publicado: (2023)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Frameless stereotactic body radiation therapy for multiple lung metastases
por: Li, Qilin, et al.
Publicado: (2014)

Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016)

Fractionated SRT using VMAT and Gamma Knife for brain metastases and gliomas — a planning study
por: Huss, Marie, et al.
Publicado: (2015)

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China
por: Zhao, Xianzhi, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Patients with Heavily Pretreated Liver Metastases and Liver Tumors
por: Lanciano, Rachelle, et al.
Publicado: (2012)

Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients
por: Kuntz, L., et al.
Publicado: (2023)

Improving stereotactic radiotherapy (SRT) planning process for brain metastases by Cyberknife system: reducing dose distribution in healthy tissues
por: Xuyao, Yu, et al.
Publicado: (2020)

Proteomic Analysis of Radiation-Induced Acute Liver Damage in a Rabbit Model
por: Jiang, Lingong, et al.
Publicado: (2019)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Radiation Fibrosis After Stereotactic Body Radiation Therapy for Osseous Metastases: A Case Report
por: Kessler, Michael R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hg86dlrh8gclv6ihfkf2crfb1b